The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Open accessAbstract
The compound U0126 (1,4-diamino-2,3-dicyano-1, 4-bis[2-aminophenylthio]butadiene) was identified as an inhibitor of AP-1 transactivation in a cell-based reporter assay. U0126 was also shown to inhibit endogenous promoters containing AP-1 response elements but did not affect genes lacking an AP-1 response element in their promoters. These effects of U0126 result from direct inhibition of the mitogen-activated protein kinase kinase family members, MEK-1 and MEK-2. Inhibition is selective for MEK-1 and -2, as U0126 shows little, if any, effect on the kinase activities of protein kinase C, Abl, Raf, MEKK, ERK, JNK, MKK-3, MKK-4/SEK, MKK-6, Cdk2, or Cdk4. Comparative kinetic analysis of U0126 and the MEK inhibitor PD098059 (Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. (1995) Proc. Natl. Acad. Sci U. S. A. 92, 7686-7689) demonstrates that U0126 and PD098059 are noncompetitive inhibitors with respect to both MEK substrates, ATP and ERK. We further demonstrate that the two compounds bind to deltaN3-S218E/S222D MEK in a mutually exclusive fashion, suggesting that they may share a common or overlapping binding site(s). Quantitative evaluation of the steady state kinetics of MEK inhibition by these compounds reveals that U0126 has approximately 100-fold higher affinity for deltaN3-S218E/S222D MEK than does PD098059. We further tested the effects of these compounds on the activity of wild type MEK isolated after activation from stimulated cells. Surprisingly, we observe a significant diminution in affinity of both compounds for wild type MEK as compared with the deltaN3-S218E/S222D mutant enzyme. These results suggest that the affinity of both compounds is mediated by subtle conformational differences between the two activated MEK forms. The MEK affinity of U0126, its selectivity for MEK over other kinases, and its cellular efficacy suggest that this compound will serve as a powerful tool for in vitro and cellular investigations of mitogen-activated protein kinase-mediated signal transduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Basic Methods in Molecular Biology
(1986) · Elsevier eBooks · doi:10.1016/b978-0-444-01082-7.x5001-2 · Cited by 3,134
Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,950
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,139
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., & Ahn, N. G. (1994) · Science · doi:10.1126/science.8052857 · Cited by 1,353
Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation
Kyriakis, J. M., & Avruch, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24313 · Cited by 1,084
Basic methods in molecular biology
Potter, H. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90137-8 · Cited by 824
Properties and Regulation of Cytosolic Phospholipase A2
Leslie, C. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16709 · Cited by 809
Carlson, B. A., Dubay, M., Sausville, E. A., Brizuela, L., & Worland, P. J. (1996) · PubMed · Cited by 580
Cited by
Items 101–193 of 193
Chen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316
Hotokezaka, H., Sakai, E., Kanaoka, K., Saito, K., Matsuo, K.-I., Kitaura, H., Yoshida, N., & Nakayama, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208284200 · Cited by 316
Stepanenko, A. A., & Dmitrenko, V. V. (2015) · Gene · doi:10.1016/j.gene.2015.08.009 · Cited by 315
Liacini, A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00180-0 · Cited by 310
Simmons, C. A., Matlis, S., Thornton, A. J., Chen, S., Wang, C.-Y., & Mooney, D. J. (2003) · Journal of Biomechanics · doi:10.1016/s0021-9290(03)00110-6 · Cited by 310
Dı́az-Rodrı́guez, E., Montero, J. C., Esparı́s-Ogando, A., Yuste, L., & Pandiella, A. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-11-0561 · Cited by 308
Davis, M. E., Cai, H., Drummond, G. R., & Harrison, D. G. (2001) · Circulation Research · doi:10.1161/hh2301.100806 · Cited by 308
Connective Tissue Growth Factor Gene Regulation
Leask, A., Holmes, A., Black, C. M., & Abraham, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210366200 · Cited by 305
Mechanisms of drug inhibition of signalling molecules
Sebolt-Leopold, J. S., & English, J. M. (2006) · Nature · doi:10.1038/nature04874 · Cited by 304
Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System
Okazawa, H., Motegi, S.-I., Ohyama, N., Ohnishi, H., Tomizawa, T., Kaneko, Y., Oldenborg, P.-A., Ishikawa, O., & Matozaki, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2004 · Cited by 302
Reuter, C. W. M., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300
Probing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 299
Lizcano, J. M., MORRICE, N. A., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490547 · Cited by 296
RetractedThomas, D. D., Espey, M. G., Ridnour, L. A., Hofseth, L. J., Mancardi, D., Harris, C. C., & Wink, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400453101 · Cited by 289
Huynh, H., Nguyen, T. T. T., Chow, K.-H. K.-P., Tan, P. H., Soo, K. C., & Tran, E. (2003) · BMC Gastroenterology · doi:10.1186/1471-230x-3-19 · Cited by 289
Lopes, M. H., Hajj, G. N. M., Muras, A. G., Mancini, G. L., Castro, R. M. P. S., Ribeiro, K. C. B., Brentani, R. R., Linden, R., & Martins, V. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2313-05.2005 · Cited by 286
Stiehl, D. P., Jelkmann, W., Wenger, R. H., & Hellwig-Bürgel, T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02247-0 · Cited by 285
Leptin mediates a proliferative response in human MCF7 breast cancer cells
Dieudonne, M.-N., Machinal-Quelin, F., Serazin-Leroy, V., Leneveu, M.-C., Pecquery, R., & Giudicelli, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00205-x · Cited by 285
Song, J., Takeda, M., & Morimoto, R. I. (2001) · Nature Cell Biology · doi:10.1038/35060068 · Cited by 284
Role of p38 and p44/42 mitogen‐activated protein kinases in microglia
Koistinaho, M., & Koistinaho, J. (2002) · Glia · doi:10.1002/glia.10151 · Cited by 281
Xu, L., Fukumura, D., & Jain, R. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108347200 · Cited by 281
Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry
Perez, O. D., & Nolan, G. P. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-155 · Cited by 279
Shibazaki, S., Yu, Z., Nishio, S., Tian, X., Thomson, R. B., Mitobe, M., Louvi, A., Velazquez, H., Ishibe, S., Cantley, L. G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn039 · Cited by 279
Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation
Meadows, K. N., Bryant, P., & Pumiglia, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108069200 · Cited by 278
Sasu, S., LaVerda, D., Qureshi, N., Golenbock, D. T., & Beasley, D. (2001) · Circulation Research · doi:10.1161/hh1501.094184 · Cited by 278
Ceramide Inhibits Protein Kinase B/Akt by Promoting Dephosphorylation of Serine 473
Schubert, K. M., Scheid, M. P., & Duronio, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13330 · Cited by 277
Chi, N.-W., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007635200 · Cited by 277
Duan, W., Chan, J. H. P., Wong, C. H., Leung, B. P., & Wong, W. S. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7053 · Cited by 277
Chemical combination effects predict connectivity in biological systems
Lehár, J., Zimmermann, G. R., Krueger, A. S., Molnar, R. A., Ledell, J. T., Heilbut, A. M., Short, G. F., Giusti, L. C., Nolan, G. P., Magid, O. A., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100116 · Cited by 275
Jazirehi, A. R., & Bonavida, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208349 · Cited by 275
Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock
Akashi, M., & Nishida, E. (2000) · Genes & Development · doi:10.1101/gad.14.6.645 · Cited by 275
Cronin, J. G., Turner, M. L., Goetze, L., Bryant, C. E., & Sheldon, I. M. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.092718 · Cited by 274
Watanabe, H., de Caestecker, M. P., & Yamada, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005724200 · Cited by 273
Ji, H., Wang, J., Nika, H., Hawke, D., Keezer, S., Ge, Q., Fang, B., Fang, X., Fang, D., Litchfield, D. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.034 · Cited by 270
Jones, N. C., Fedorov, Y. V., Rosenthal, R. S., & Olwin, B. B. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200101)186:1<104::aid-jcp1015>3.0.co;2-0 · Cited by 271
Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells
Fan, V. H., Au, A., Tamama, K., Littrell, R., Richardson, L. B., Wright, J. W., Wells, A., & Griffith, L. G. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0320 · Cited by 269
Sapkota, G. P., Kieloch, A., Lizcano, J. M., Lain, S., Arthur, J. S. C., Williams, M. R., Morrice, N., Deak, M., & Alessi, D. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009953200 · Cited by 267
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., & Barr, R. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.016 · Cited by 266
Fan, J., & Malik, A. B. (2003) · Nature Medicine · doi:10.1038/nm832 · Cited by 264
Morón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262
“Although PI 3-kinase modulates MAPKs in several cell lines, LY294002, a selective PI 3-kinase inhibitor (Vlahos et al., 1994), did not alter ERK1 and ERK2 phosphorylation, suggesting that Figure 5.”
InfluentialCI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Scherle, P. A., Jones, E. A., Favata, M. F., Daulerio, A. J., Covington, M. B., Nurnberg, S. A., Magolda, R. L., & Trzaskos, J. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5681 · Cited by 256
Self-citationCastellana, D., Zobairi, F., Martinez, M. C., Panaro, M. A., Mitolo, V., Freyssinet, J.-M., & Kunzelmann, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1946 · Cited by 255
Satoh, T., Nakatsuka, D., Watanabe, Y., Nagata, I., Kikuchi, H., & Namura, S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01229-5 · Cited by 252
Intestinal myofibroblasts in innate immune responses of the intestine
Otte, J.-M., Rosenberg, I. M., & Podolsky, D. K. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00403-7 · Cited by 242
Xiao, L., Xu, H., Zhang, Y., Wei, Z., He, J., Jiang, W., Li, X., Dyck, L. E., Devon, R. M., Deng, Y., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002064 · Cited by 191
Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells
Pattabiraman, P. P., & Rao, P. V. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2009 · Cited by 189
BOST, F., CARON, L., MARCHETTI, I., DANI, C., MARCHAND-BRUSTEL, Y. L., & BINÉTRUY, B. (2002) · Biochemical Journal · doi:10.1042/bj3610621 · Cited by 184
Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H., & Chandran, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1524-1539.2003 · Cited by 175
“U0126 is a potent and specific covalent binding inhibitor of MEK1/2 and shows little, if any, effect on the kinase activities of PKC, Abl, cRaf-1, MEKK, ERK, JNK, MKK-3, MKK-4/SEK, MKK-6, Cdk2, or Cdk4 (20).”
BackgroundNelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., Legro, R. S., Kimball, S. R., Strauss, J. F., & McAllister, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0178 · Cited by 167
IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK
Moore, P. E., Church, T. L., Chism, D. D., Panettieri, R. A., & Shore, S. A. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00245.2001 · Cited by 166
Chen, M. J., Nguyen, T. V., Pike, C. J., & Russo-Neustadt, A. A. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.028 · Cited by 158
Verhaegen, M., Bauer, J. A., Martín de la Vega, C., Wang, G., Wolter, K. G., Brenner, J. C., Nikolovska-Coleska, Z., Bengtson, A., Nair, R., Elder, J. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1748 · Cited by 140
Ghrelin Directly Stimulates Glucagon Secretion from Pancreatic α-Cells
Chuang, J.-C., Sakata, I., Kohno, D., Perello, M., Osborne-Lawrence, S., Repa, J. J., & Zigman, J. M. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1001 · Cited by 141
Lee, S. J., Drabik, K., Van Wagoner, N. J., Lee, S., Choi, C., Dong, Y., & Benveniste, E. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4658 · Cited by 137
Mori, T., Wang, X., Aoki, T., & Lo, E. H. (2002) · Journal of Neurotrauma · doi:10.1089/089771502320914642 · Cited by 129
Liang, K., Lee, C., Lin, W., Lin, C., Wu, C., Luo, S., & Yang, C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20992 · Cited by 128
Reistad, T., Mariussen, E., Ring, A., & Fonnum, F. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl198 · Cited by 125
“Phosphorylation of ERK, shown by Western blotting, was fully inhibited by pretreatment with U0126, which inhibits the ERK branch of the MAP-kinase pathway (Duncia et al., 1998; Favata et al., 1998).”
BackgroundMethodInfluentialCoffee Phenolic Phytochemicals Suppress Colon Cancer Metastasis by Targeting MEK and TOPK
Kang, N. J., Lee, K. W., Kim, B. H., Bode, A. M., Lee, H.-J., Heo, Y.-S., Boardman, L., Limburg, P., Lee, H. J., & Dong, Z. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr022 · Cited by 123
McFall, A., ülkuü, A., Lambert, Q. T., Kusa, A., Rogers-Graham, K., & Der, C. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5488-5499.2001 · Cited by 120
“We thank Julian Downward for providing the p110a-CAAX cDNA construct, Johannes Bos for providing the pMT2-HA-Rlf-CAAX construct, James Trzaskos (Dupont) for providing U0126, Heena Mehta and Staeci Morita for technical support, and Misha Rand for preparation of figures.”
Quilliam, L. A., Castro, A. F., Rogers-Graham, K. S., Martin, C. B., Der, C. J., & Bi, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23850 · Cited by 119
Nejmeddine, M., Negi, V. S., Mukherjee, S., Tanaka, Y., Orth, K., Taylor, G. P., & Bangham, C. R. M. (2009) · Blood · doi:10.1182/blood-2008-03-136770 · Cited by 118
Kwon, M., Fernandez, J. R., Zegarek, G. F., Lo, S. B., & Firestein, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6785-10.2011 · Cited by 115
Growth factor signaling to mTORC1 by amino acid–laden macropinosomes
Yoshida, S., Pacitto, R., Yao, Y., Inoki, K., & Swanson, J. A. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201504097 · Cited by 105
Mathews, E. S., & Appel, B. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0726-16.2016 · Cited by 97
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
Marcher, A.-B., Bendixen, S. M., Terkelsen, M. K., Hohmann, S. S., Hansen, M. H., Larsen, B. D., Mandrup, S., Dimke, H., Detlefsen, S., & Ravnskjaer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39112-6 · Cited by 95
Hypochlorous Acid Stimulation of the Mitogen-Activated Protein Kinase Pathway Enhances Cell Survival
Midwinter, R. G., Vissers, M. C. M., & Winterbourn, C. C. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2530 · Cited by 90
ERK1/2 Antagonizes Glycogen Synthase Kinase-3β-induced Apoptosis in Cortical Neurons
Hetman, M., Hsuan, S.-L., Habas, A., Higgins, M. J., & Xia, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111227200 · Cited by 88
Hansen, S. H., Zegers, M. M. P., Woodrow, M., Rodriguez-Viciana, P., Chardin, P., Mostov, K. E., & McMahon, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9364-9375.2000 · Cited by 85
Chévere-Torres, I., Kaphzan, H., Bhattacharya, A., Kang, A., Maki, J. M., Gambello, M. J., Arbiser, J. L., Santini, E., & Klann, E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.028 · Cited by 83
Activin E controls energy homeostasis in both Brown and white adipose tissues as a hepatokine
Hashimoto, O., Funaba, M., Sekiyama, K., Doi, S., Shindo, D., Satoh, R., Itoi, H., Oiwa, H., Morita, M., Suzuki, C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.008 · Cited by 77
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Sukka, S. R., Ampomah, P. B., Darville, L. N. F., Ngai, D., Wang, X., Kuriakose, G., Xiao, Y., Shi, J., Koomen, J. M., McCusker, R. H., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01115-7 · Cited by 82
“43), a selective inhibitor of MEK and ERK, blocked the efferocytosis-induced increases in nuclear AhR (Fig.”
Targeting MAPK Signaling in Age-Related Macular Degeneration
Kyosseva, S. V. (2016) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s32200 · Cited by 74
Chen, J. C., Zhuang, S., Nguyen, T. H., Boss, G. R., & Pilz, R. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207943200 · Cited by 71
LIN, C., TSENG, H., HSIEH, H., LEE, C., WU, C., CHENG, C., & YANG, C. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.032 · Cited by 65
“In this study, our results suggest that TNF-α-induced MMP-9 expression is mediated through activation of p42/p44 MAPK in A549 cells, since pretreatmentwithU0126, a selective inhibitor ofMEK1/2 (Favata et al., 1998), attenuated TNF-α-induced MMP-9 expression and p42/p44 MAPK phosphorylation in these cells.”
BackgroundMethodCytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway
Miranda, M. B., Xu, H., Torchia, J. A., & Johnson, D. E. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.03.016 · Cited by 62
Rapid activation of ERK by 6‐hydroxydopamine promotes survival of dopaminergic cells
Lin, E., Cavanaugh, J. E., Leak, R. K., Perez, R. G., & Zigmond, M. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21478 · Cited by 62
Rieg, A. D., Suleiman, S., Anker, C., Verjans, E., Rossaint, R., Uhlig, S., & Martin, C. (2018) · Respiratory Research · doi:10.1186/s12931-018-0829-5 · Cited by 59
“[51]; MAP2K: 5 μM U0126 (IC50: 58–72 nM) [52]; p38-MAPK: 5 μM SB203580 (IC50: 0.”
Aam, B. B., & Fonnum, F. (2007) · Archives of Toxicology · doi:10.1007/s00204-006-0164-3 · Cited by 57
Yap, J. J., Chartoff, E. H., Holly, E. N., Potter, D. N., Carlezon, W. A., & Miczek, K. A. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3796-7 · Cited by 55
“U0126 is highly selective for MEK-1 and MEK-2, and U0126 shows little, if any, effect on the kinase activities of protein kinase C, Abl, Raf, MEKK, ERK, JNK, MKK-3, MKK-4/SEK, MKK6, Cdk2, or Cdk4 (Dudley et al. 1995; Favata et al. 1998).”
Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1631-3 · Cited by 52
Effect of WAVE2 Phosphorylation on Activation of the Arp2/3 Complex
Nakanishi, O., Suetsugu, S., Yamazaki, D., & Takenawa, T. (2006) · Journal of Biochemistry · doi:10.1093/jb/mvm034 · Cited by 50
HDAC inhibition ameliorates cone survival in retinitis pigmentosa mice
Samardzija, M., Corna, A., Gomez-Sintes, R., Jarboui, M. A., Armento, A., Roger, J. E., Petridou, E., Haq, W., Paquet-Durand, F., Zrenner, E., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00653-3 · Cited by 48
Lipponen, A., El-Osta, A., Kaspi, A., Ziemann, M., Khurana, I., KN, H., Navarro-Ferrandis, V., Puhakka, N., Paananen, J., & Pitkänen, A. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0519-z · Cited by 47
“AS-703026 (also known as pimasertib) and U0126 are MEK1/2 inhibitors [30, 56].”
BackgroundLiu, J., Ahlborn, T. E., Briggs, M. R., & Kraemer, F. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5214 · Cited by 47
Groeger, G., Doonan, F., Cotter, T. G., & Donovan, M. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10525 · Cited by 45
Learned stressor resistance requires extracellular signal-regulated kinase in the prefrontal cortex
Christianson, J. P., Flyer-Adams, J. G., Drugan, R. C., Amat, J., Daut, R. A., Foilb, A. R., Watkins, L. R., & Maier, S. F. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00348 · Cited by 39
Nicolaou, F., Teodoridis, J. M., Park, H., Georgakis, A., Farokhzad, O. C., Böttinger, E. P., Da Silva, N., Rousselot, P., Chomienne, C., Ferenczi, K., et al. (2003) · Blood · doi:10.1182/blood-2002-01-0324 · Cited by 39
Guo, B., & Rothstein, T. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5375 · Cited by 31
Camargo-Sosa, K., Colanesi, S., Müller, J., Schulte-Merker, S., Stemple, D., Patton, E. E., & Kelsh, R. N. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1007941 · Cited by 31
“Tyrphostin AG-1478 is an inhibitor of the Epidermal Growth Factor Receptor (EGFR)[29] 482 while U0126, PD98059 and PD325901 are highly selective inhibitors of MEK1/2 483 signalling [30-32].”
BackgroundRouget, R., Auclair, Y., Loignon, M., Affar, E. B., & Drobetsky, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706257200 · Cited by 30
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Charaf, L., Mahon, F.-X., Lamrissi-Garcia, I., Moranvillier, I., Beliveau, F., Cardinaud, B., Dabernat, S., de Verneuil, H., Moreau-Gaudry, F., & Bedel, A. (2017) · Leukemia · doi:10.1038/leu.2016.154 · Cited by 16
ERK signaling is required for eye-specific retino-geniculate segregation
Naska, S., Cenni, M. C., Menna, E., & Maffei, L. (2004) · Development · doi:10.1242/dev.01212 · Cited by 14
Metadata
- Authors
- Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., & Trzaskos, J. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 273
- Issue
- 29
- Pages
- 18623-18632
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2086262311
- Cited by
- 3,015
- References
- 40
- FWCI
- 48.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.